Navigation Links
Gene's novel role may provide key to treating liver and neurodegenerative diseases
Date:7/2/2009

nd Xu, there is also significant existing evidence that FAIM prevents neuron death and promotes neural outgrowth.

They hypothesize that FAIM might play a role in neuron protection, making it a potential therapeutic target for neurodegenerative diseases such as Alzheimer's and Parkinson's. Eventually, the Singapore scientists hope to conduct drug screens on FAIM to determine how it can be used to prolong or delay cell survival, and provide solutions to a wide variety of human diseases.

Drs. Huo and Xu's interest in FAIM was sparked by the work of their colleagues in BTI's animal cell technology group, which since 2007 has been using FAIM to enhance the longevity of biologics-producing cells to increase their yield in bioreactors, which are vessels in which organisms are cultured, and biochemically active substances derived from them.

Biologics are medicinal products such as vaccines, allergenics, tissues and recombinant proteins that can be extracted from natural sources (human, animal, or microorganism) and produced by biotechnology methods.

Curious about FAIM's role in immune cells, particularly its increased expression in activated B cells, key effectors of the human immune system responsible for fighting viruses and other pathogens that invade the body, the two scientists began developing the first in vivo knockout mouse model to closely examine FAIM's role in preventing programmed cell death.

BTI Executive Director Miranda Yap, Ph.D., said, "The Immunology Group's venturing beyond the traditional boundaries of applied science has paid off with their discovery of a second role for FAIM in the seemingly unrelated field of immunology. Their work is indeed a fine example of how our scientists are constantly pushing the envelope to keep at the forefront of biomedical research."


'/>"/>

Contact: Cathy Yarbrough
sciencematter@yahoo.com
858-243-1814
Agency for Science, Technology and Research (A*STAR), Singapore
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Pathway links inflammation, angiogenesis and breast cancer
2. Traffic Fumes Plus Genes Boosts Kids Asthma Risk
3. New Database to Help Speed Search for Bipolar Disorder Genes
4. Is Perfect Pitch All in the Genes?
5. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
6. Genes Boost Risk for Rheumatoid Arthritis, Lupus
7. The genes involved in rheumatoid arthritis identified
8. If you think cancer genes are simple, you dont know JAK
9. Test for lung cancer looks for discomforting quiet among protective genes
10. Hushed Genes Might Mean Higher Lung Cancer Risk
11. EURYI project to understand how the brain wires during embryogenesis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)..., WASHINGTON, Nov. 6 ...storic three-day conference in the nation,s capita... agency - to end veteran homelessness in five year...care specialists, representatives of federal agenc... low-income veterans, and community- and faith-bas...
(Date:11/6/2009)..., WASHINGTON, Nov. 6 /PRNewswire-USNewswire/ ...pment organization with offices in 66 countries ar...esentations on children,s health and well-being at... (APHA) Annual Meeting & Exposition in Philade... The American Public Health Association gathers or...
(Date:11/6/2009)... A survey released today f...f physicians surveyed (74 percent) feel they have ...han they did five years ago. , ... survey released today from Jackson Healthcare r...4 percent) feel they have less control over the wa...
(Date:11/6/2009)...hort-term limitations seem to wane as years go by,...lthDay News) -- New research suggests that people ...ive years of developing the disease are more likel...erm than others with the condition. , The findi...ople with the disease who relapse within five year...
(Date:11/6/2009)... School nurses mistakenly ... vaccine, and medical malpractice lawyers, includi...f wrongful injections are not being reported. , ...November 6, 2009 -- Across New York, medical malp...ts were given the swine flu vaccine by public scho...
Breaking Medicine News(10 mins):Health News:VA Summit Frames Plan to End Veteran Homelessness 2Health News:Plan's Expertise Highlighted at Premier Health Forum 2Health News:Physicians Losing Control of Medicine: New Survey Reports Medical Malpractice as Primary Reason, 2Health News:Physicians Losing Control of Medicine: New Survey Reports Medical Malpractice as Primary Reason, 3Health News:Physicians Losing Control of Medicine: New Survey Reports Medical Malpractice as Primary Reason, 4Health News:Early Relapse of MS May Mean Fewer Issues Later 2Health News:New York Medical Malpractice Lawyer Comments on School Nurses Injecting Students with Swine Flu Vaccine without Consent 2Health News:New York Medical Malpractice Lawyer Comments on School Nurses Injecting Students with Swine Flu Vaccine without Consent 3
...etic disorder characterized by distorted, sickle s...ith severe pain, fatigue, and organ damage to the ...e is // prevalent in African populations where the...cy and duration of the crises can be lessened by r...
...world are gathering for National Association of Ne...eview that data and discuss ways of preventing occ...han 300,000 premature infants are born prior to 36...patients susceptible to respiratory illnesses. Dur...
...as electronic wristbands is developed to deliver b...uces Human errors. Wristbands are developed which ...nd // treatment requirements are being used in hos...ne used in shops to detect theft of goods. A stude...
...ly have been reported to experience 25% less muscl...are less active. Furthermore, the study has also r.../ brisk aerobic exercise, such as running, experie... pain in a group of runners and a group of communi...
...new studies point in the direction that a dose of ...ast cancer.// "High levels of daily stress are ...ncer". According to a study carried out at the ... - low, medium or high. Symptoms accompanying the ...
...ts, placement of stents that release the medicatio...arrowing nine months following angioplasty for pat...ing to an article in the September 14 issue of JAM...icle. These stents (which release medications, suc...
Other Medicine News:Health News:Hydroxyurea Treatment For Children With Sickle Cell Disease 2Health News:Stents That Release Medication To Check Artery Narrowing 2
(Date:11/6/2009)...ON, S.C., Nov. 6 The ...n South Carolina and Georgia throughout the week o... uninsured and financially-struggling patients acc...ion medicines for free or nearly free. With the na... the Partnership for Prescription Assistance (PPA)...
(Date:11/6/2009)...Mass., Nov. 6 Boston Sci...that it has reached an agreement in principle with...roduct advisories issued by its Guidant subsidiary...ccurred prior to Boston Scientific,s 2006 acquisit...usly disclosed an investigation by the U.S. Attorn...
(Date:11/6/2009)..., Nov. 6 Keryx Biopharma...rence call on Tuesday, November 10, 2009 at 8:30 a...l results and business outlook for the remainder o...he Company, will host the call. Keryx will announ...s release to be issued prior to the call. ,, In...
Breaking Medicine Technology:Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 2Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 3Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 3Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 4Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 5Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 6Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 7Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 8Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 9Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 10Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 11Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 12Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 13Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 14Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 15Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 16Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 17Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2Biologists devise unifying framework to explain evolutionary puzzles 8721 1Biologists devise unifying framework to explain evolutionary puzzles 8721 2LOHAS Announces Final Program Line up Including Speakers from Wal Mart Coca Cola MINI Facebook Causes Saatchi 26 SaatchiS Gaiam and eBay 47970 1LOHAS Announces Final Program Line up Including Speakers from Wal Mart Coca Cola MINI Facebook Causes Saatchi 26 SaatchiS Gaiam and eBay 47970 2Avoid the Burn 3A First Sunscreen to Earn the Melanoma International Foundation Seal of Approval Expands Distribution Throughout Northern California 47968 1Avoid the Burn 3A First Sunscreen to Earn the Melanoma International Foundation Seal of Approval Expands Distribution Throughout Northern California 47968 2Avoid the Burn 3A First Sunscreen to Earn the Melanoma International Foundation Seal of Approval Expands Distribution Throughout Northern California 47968 3
...Will facilitate tight integration between sponsors...Velos, Inc., a recognized,leader and trusted resou...ems and member of the Oracle PartnerNetwork, will ...earch and Oracle Clinical. Both software,products ...h is widely,installed at research sites, while Ora...
...Potential First-in-Class Treatment for Type 2 Diab...., a,biopharmaceutical company focused on the disc... for the treatment of metabolic diseases,announced...hy subjects in a,Phase 1 clinical trial of MBX-298... diabetes., The Phase 1 clinical trial will evalu...
Other Medicine Technology:Velos to Develop Key System Interface for Clinical Research 2Velos to Develop Key System Interface for Clinical Research 3Velos to Develop Key System Interface for Clinical Research 4Metabolex Initiates Phase 1 Trial of MBX-2982 2
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
Medicine Products: